Home Cart Sign in  
Chemical Structure| 464930-42-5 Chemical Structure| 464930-42-5

Structure of SSR240612
CAS No.: 464930-42-5

Chemical Structure| 464930-42-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SSR240612 is a potent and selective non-peptide bradykinin B1 receptor antagonist with Kis of 0.48 nM and 0.73 nM for B1 kinin receptors of human fibroblast MRC5 and HEK cells expressing human B1 receptors, 481 nM and 358 nM for B2 receptors of guinea pig ileum membranes and CHO cells expressing human B1 receptor, respectively.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SSR240612

CAS No. :464930-42-5
Formula : C42H53ClN4O7S
M.W : 793.41
SMILES Code : [H]Cl.O=C(C[C@@H](NS(C1=CC(C=CC(OC)=C2)=C2C=C1)(=O)=O)C3=CC=C(OCO4)C4=C3)N[C@@H](C(N(C)C(C)C)=O)CC5=CC=C(C=C5)CN6[C@H](C)CCC[C@@H]6C
MDL No. :MFCD09260115

Safety of SSR240612

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of SSR240612

GPCR

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Nephrotoxic serum-induced glomerulonephritis Oral 10 mg/kg Every other day for six weeks To evaluate the effect of a B1 receptor antagonist on glomerular C3 deposition in mice with glomerulonephritis. Results showed that the B1 receptor antagonist significantly reduced C3 deposition in glomeruli. EBioMedicine. 2019 Sep;47:319-328

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.26mL

0.25mL

0.13mL

6.30mL

1.26mL

0.63mL

12.60mL

2.52mL

1.26mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories